β-lactamase epidemiology and the utility of established and novel β-lactamase inhibitors

Expert Opinion on Investigational Drugs

Volumn 9, Issue 2, 2000, Pages 247-261

  Payne, D J ^a   Du, W ^a   Bateson, J H ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Metallo lactamases; Novel lactamase inhibitors; lactamase inhibitors; lactamases

Indexed keywords

6 (1 METHYL 1,2,3 TRIAZOL 4 YLMETHYLENE)PENEM 3 CARBOXYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; BACTERIAL ENZYME; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CAPTOPRIL; CEPHEM DERIVATIVE; MONOBACTAM DERIVATIVE; PENAM DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; RO 47 9455; SB 206999; SB 252619; SB 255666; SULPERAZON; SULTAMICILLIN; SYN 2190; TETRAZOLE DERIVATIVE; THIORPHAN; TIMENTIN; UNCLASSIFIED DRUG;

BACTERIAL INFECTION; DRUG DESIGN; DRUG RESEARCH; ENZYME ACTIVE SITE; HUMAN; NONHUMAN; REVIEW; SEQUENCE ANALYSIS;

EID: 0033963352     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.9.2.247     Document Type: Review

References (74)